Skip to main content

Table 2 Univariate and multivariate analyses of factors predicting disease-free survival (n = 38)

From: Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients

 

Univariate

Multivariate

 

RR

95 % CI

P-value

RR

95 % CI

P-value

Age

1.149

0.3154 – 4.190

0.8328

1.162

0.1601 – 4.622

0.8607

FIGO stage

1.877

0.4963 – 7.102

0.3535

2.524

0.2284 – 27.89

0.4501

Lymph node metastasis

1.937

0.5174 – 7.248

0.3263

1.197

0.4152 – 8.85

0.4044

Parametrium invasion

3.155

0.9579 – 11.76

0.0681

1.716

0.0402 – 8.416

0.691

Margin positive

3.884

0.3645 – 685.0

0.1581

1.604

0.03867 – 10.06

0.7392

Primary tumor > 4 cm

0.3786

0.05758 – 1.266

0.1609

0.3811

0.2314 – 29.76

0.4362

Serum SCC antigen > 5.0 ng/mL

0.6878

0.1982 – 2.365

0.5545

0.2663

0.04308 – 1.646

0.1545

LVSI

8.698

1.508 – 18.00

0.011*

9.764

0.7944 – 120.0

0.07506

Shrinkage rate 50 %

6.098

2.328 – 37.18

0.0021*

12.14

1.023 – 144.1

0.04794*

  1. RR Relative risk, CI Confidence interval, Univariate analysis, Log rank test; Multivariate analysis, Cox proportional hazard model; *significant p-value